Clinical Trial Update: Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating olanzapine for prevention of chemotherapy-induced nausea and vomiting in gynecologic cancer patients. The study was terminated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Gynecologic Cancer | Phase 3 | Status: TERMINATED | Results posted: 2025-06-18